Profile data is unavailable for this security.
About the company
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a China-based company mainly engaged in research and development, manufacturing and marketing of biomedicine. The Company's products include aminolevulinic acid hydrochloride topical powder (trade name: ALA) and hemporfin or injection (trade name: FuMeiDa), and doxorubicin hydrochloride liposome injection (trade name: LIBOd), among others. Its products are mainly used for skin venereal disease treatment and anti-tumor treatment. The Company conducts its businesses in the domestic market.
- Revenue in HKD (TTM)919.49m
- Net income in HKD117.41m
- Incorporated1996
- Employees948.00
- LocationShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co LtdZhangjiang Hi-tech ParkNo.308 Cailun RoadPudong District, Zhangjiang Hi-tech ParkSHANGHAI 201210ChinaCHN
- Phone+86 2 158553583
- Fax+86 2 158553893
- Websitehttp://www.fd-zj.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alphamab Oncology | 236.45m | -227.61m | 4.29bn | 435.00 | -- | 2.38 | -- | 18.16 | -0.2367 | -0.2367 | 0.2463 | 1.87 | 0.1028 | 0.7705 | 19.34 | 543,573.90 | -9.90 | -18.72 | -11.69 | -21.94 | 74.75 | -- | -96.26 | -415.55 | 5.55 | -- | 0.1333 | -- | 31.12 | -- | 35.35 | -- | -- | -- |
| Jiangsu Recbio Technology Co Ltd | 0.00 | -618.18m | 4.41bn | 472.00 | -- | 3.78 | -- | -- | -1.29 | -1.29 | 0.00 | 2.42 | 0.00 | -- | -- | 0.00 | -25.47 | -- | -30.68 | -- | -- | -- | -- | -- | 2.33 | -- | 0.378 | -- | -- | -- | 20.86 | -- | -- | -- |
| Consun Pharmaceutical Group Ltd | 2.80bn | 847.94m | 4.64bn | 3.13k | 5.39 | 1.18 | 4.97 | 1.66 | 1.06 | 1.06 | 3.50 | 4.83 | 0.4981 | 2.08 | 9.10 | 895,247.90 | 15.13 | 12.04 | 22.57 | 19.25 | 74.19 | 74.55 | 30.37 | 24.89 | 2.62 | -- | 0.1155 | 41.53 | 10.71 | 7.03 | 14.88 | 11.01 | -- | 18.43 |
| Ascentage Pharma Group International | 239.92m | -1.00bn | 5.02bn | 583.00 | -- | 76.88 | -- | 20.93 | -3.53 | -3.53 | 0.8499 | 0.225 | 0.0833 | 2.38 | 2.22 | 411,533.60 | -34.73 | -44.93 | -52.82 | -57.04 | 86.24 | 87.68 | -417.02 | -976.10 | 1.42 | -15.03 | 0.9622 | -- | 5.85 | 100.76 | -4.84 | -- | 2.82 | -- |
| Sihuan Pharmaceutical Holdings Group Ltd | 2.01bn | -58.38m | 5.04bn | 2.87k | -- | 1.05 | 116,536.80 | 2.51 | -0.0063 | -0.0063 | 0.2163 | 0.5134 | 0.1572 | 0.8657 | 2.35 | 700,174.90 | -2.18 | -6.85 | -3.34 | -9.10 | 69.64 | 75.81 | -13.85 | -36.23 | 1.37 | -0.5119 | 0.1863 | -- | -14.70 | -8.60 | 97.23 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 668.08m | -129.02m | 5.04bn | 745.00 | -- | 3.53 | -- | 7.55 | -0.2533 | -0.2533 | 1.31 | 2.80 | 0.2732 | 1.35 | 2.53 | -- | -5.28 | -- | -7.02 | -- | 66.16 | -- | -19.31 | -- | 0.8383 | -7.47 | 0.2352 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -269.50m | 5.26bn | 133.00 | -- | 4.77 | -- | -- | -1.35 | -1.35 | 0.00 | 5.45 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 6.41 | -- | 0.0185 | -- | -- | -- | 65.62 | -- | -- | -- |
| Microport NeuroTech Ltd | -100.00bn | -100.00bn | 5.28bn | 571.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 21.61 | -- | 768.73 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 5.59bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -28.25 | -- | 5.82 | -- | -- | -- |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 919.49m | 117.41m | 6.30bn | 948.00 | 18.58 | 0.8624 | -- | 6.85 | 0.1141 | 0.1141 | 0.8748 | 2.46 | 0.2907 | 1.81 | 1.79 | 969,922.90 | 3.71 | 7.03 | 4.64 | 9.05 | 91.06 | 92.17 | 12.75 | 17.26 | 3.62 | 151.72 | 0.0073 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | 0.00 |
| Tong Ren Tang Technologies Co Ltd | 7.32bn | 637.89m | 6.31bn | 4.10k | 9.90 | 0.848 | 4.61 | 0.8625 | 0.498 | 0.498 | 5.72 | 5.81 | 0.5212 | 0.9835 | 5.68 | 1,785,144.00 | 7.64 | 7.68 | 12.10 | 12.32 | 42.04 | 43.50 | 14.65 | 16.11 | 2.37 | -- | 0.1443 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | 0.0178 |
| New Horizon Health Ltd | 1.47bn | 119.56m | 6.47bn | 1.04k | 59.10 | 2.00 | 41.57 | 4.40 | 0.2392 | 0.2392 | 3.22 | 7.05 | 0.4536 | 2.16 | 2.08 | 1,676,600.00 | 3.67 | -- | 3.99 | -- | 88.74 | -- | 8.10 | -- | 10.50 | -- | 0.1305 | -- | 259.54 | -- | 97.40 | -- | -- | -- |
| China Shineway Pharmaceutical Group Ltd | 4.88bn | 1.05bn | 7.73bn | 3.53k | 6.74 | 1.02 | 6.24 | 1.58 | 1.39 | 1.39 | 6.46 | 9.19 | 0.5073 | 1.44 | 6.31 | -- | 10.89 | 8.03 | 14.15 | 9.77 | 75.15 | 74.55 | 21.47 | 17.87 | 2.98 | -- | 0.0411 | 45.79 | 14.32 | 11.94 | 34.14 | 13.89 | -- | 12.88 |
| Beijing Tong Ren Tang Chinese Medicine | 1.52bn | 540.39m | 7.77bn | 798.00 | 14.38 | 2.01 | 11.54 | 5.09 | 0.6456 | 0.6456 | 1.82 | 4.62 | 0.3522 | 0.6449 | 2.31 | 1,910,959.00 | 13.64 | 16.71 | 15.50 | 18.75 | 68.67 | 69.88 | 38.73 | 40.72 | 8.59 | -- | 0.0317 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| Lepu Biopharma Co Ltd | 243.56m | -23.88m | 7.80bn | 429.00 | -- | 8.05 | 97.35 | 32.02 | -0.0144 | -0.0144 | 0.1468 | 0.5842 | 0.0917 | 1.06 | 1.62 | 567,748.90 | -1.23 | -- | -1.91 | -- | 87.45 | -- | -13.45 | -- | 0.7201 | 0.1392 | 0.4549 | -- | 1,347.16 | -- | 96.79 | -- | -- | -- |
| Everest Medicines Ltd | 136.11m | -912.71m | 7.81bn | 432.00 | -- | 1.43 | -- | 57.40 | -2.92 | -2.92 | 0.4348 | 16.82 | 0.0203 | 2.25 | 4.57 | 315,068.20 | -13.63 | -30.52 | -15.06 | -33.14 | 72.67 | -- | -670.57 | -5,745.25 | 8.29 | -- | 0.0979 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
Data as of Apr 26 2024. Currency figures normalised to Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's reporting currency: Hong Kong Dollar HKD
7.07%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Invesco Hong Kong Ltd.as of 30 Sep 2023 | 19.50m | 5.98% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 3.02m | 0.93% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 462.00k | 0.14% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 52.00k | 0.02% |
| DFA Australia Ltd.as of 31 Dec 2023 | 15.45k | 0.01% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
| Ping An Fund Management Co., Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
| Asset Management One Co., Ltd.as of 24 Nov 2022 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
